Camille Ragin, Ph.D., M.P.H.
Dr. Ragin has a PhD in Virology from the Department of Infectious Disease and Microbiology and a Master in Public Health in Epidemiology from the Department of Epidemiology at the University of Pittsburgh’s Graduate School of Public Health. This very rare but exciting combination of skills has enabled her to apply molecular markers in epidemiological studies. She is an outstanding Jamaican-American scientist who is committed to the improvement of cancer prevention and treatment strategies in order to reduce the disparities among minority populations.
Dr. Ragin has extensive experience in epidemiological study design, administration and data analysis and has conducted a number of collaborative studies that apply disciplines such as molecular virology and public health to cancer research. Dr. Ragin is committed to the improvement of cancer prevention and treatment strategies in order to reduce the disparities among minority populations. Her research focuses on viral-gene interactions and cancer health disparities. She has conducted numerous studies related to Human Papillomavirus in cervical, lung and oropharyngeal cancers as well as Human Herpes virus 8 in prostate cancer. Many of Dr. Ragin’s research studies involve populations not only from the Pittsburgh area but world-wide, from Africa, Europe and the Caribbean. This research experience allowed her to establish a network of collaborators which stemmed her conceptualization of the African-Caribbean Cancer Consortium (AC3). The AC3 focuses on studies of viral and genetic risk factors related to cancer in populations of African descent. As principal investigator of the AC3 she has led the charge to further promote and expand the level of cancer prevention research in at risk minority populations.
<< Previous | Next >>